Immuron IMRN
NASDAQ IMRN
$0.95 +0.00 (+0.44%)
At close: Oct 23, 2026 · 4:00 PM EDT

Immuron (IMRN) Net Income towards Common Stockholders (2023 - 2024)

Updated

Immuron (IMRN) posted Net Income towards Common Stockholders of -$3.82 million for FY2026 (year ended Aug 28, 2026).

Analysis

Immuron (IMRN) Net Income towards Common Stockholders (2023 - 2024) Analysis & Trends

Since FY2015, Immuron has reported Net Income towards Common Stockholders for 12 fiscal years.

  • Annual Net Income towards Common Stockholders has run from a low of -$5.22 million in FY2025 to a high of -$69,347 in FY2024 over five years.
  • Business Quant data shows IMRN's Net Income towards Common Stockholders at -$5.22 million in FY2025, -$69,347 in FY2024, -$2.07 million in FY2023 and -$1.88 million in FY2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 7.10 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 210.00 Mn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 3.61 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn -1.34 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 3.26 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 2.51 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 2.38 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn -10.50 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn -248.00 Mn
10 Immuron 7.13 Mn -10.02 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 -4.54 Mn
Sep 9, 2024 -46,223.37
Dec 31, 2023 -24,649.80
API Access

Immuron Net Income towards Common Stockholders API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-income-towards-common-stockholders&ticker=IMRN&period=max&api_key=YOUR_API_KEY